Single-session radioembolization for small HCC reduces charges, travel, and time to treatment

Single-session ablative radioembolization for small hepatocellular carcinoma cut hospital charges 27.4% ($86,193 vs $118,656), shortened time to treatment by 15 days, and reduced travel burden by 42.6% compared with conventional two-session TARE.

• Retrospective single-center study of 312 treatment episodes (96 single-session, 216 conventional) in 255 patients with HCC.
• Single-session TARE success rate was 96.9% using glass microspheres.
• Modeld IR physician work RVUs were reduced by 17.9%.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.